Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 372

Results For "EU"

4784 News Found

Agilent establishes Centre for Excellence at Gujarat Technological University
Medical Device | March 17, 2022

Agilent establishes Centre for Excellence at Gujarat Technological University

The facility will enable research initiatives in analytical chemistry, biopharmaceuticals, and life sciences


Beghou Consulting strengthens advanced analytics and data science team in Pune
News | March 17, 2022

Beghou Consulting strengthens advanced analytics and data science team in Pune

Since 1993, Beghou Consulting has helped life sciences companies - especially emerging pharmaceutical companies - establish and manage commercial operations to better market and sell therapies


Roche introduces molecular testing solutions to differentiate Covid-19 variants
Medical Device | March 17, 2022

Roche introduces molecular testing solutions to differentiate Covid-19 variants

Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and Delta


Lynparza reduced risk of death by 32% in the adjuvant treatment of patients with breast cancer
Drug Approval | March 17, 2022

Lynparza reduced risk of death by 32% in the adjuvant treatment of patients with breast cancer

First PARP inhibitor to demonstrate overall survival benefit in early breast cancer


Biological E gears up for new phase of vaccination drive
News | March 17, 2022

Biological E gears up for new phase of vaccination drive

To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India


Wockhardt’s novel antibiotic Phase 1 trial to be conducted by NIH, USA
Biotech | March 16, 2022

Wockhardt’s novel antibiotic Phase 1 trial to be conducted by NIH, USA

The USFDA has granted a qualified infectious disease product (QIDP) designation to WCK 6777, which signifies its ability to meet unmet medical needs and facilitates a faster approval process


Sanofi announces €300 million collaboration with Blackstone Life Sciences
Biotech | March 16, 2022

Sanofi announces €300 million collaboration with Blackstone Life Sciences

The investment will accelerate the overall Sarclisa development program


Jeffrey W. Fisher is the recipient of the Arnold J Lehman SOT award
News | March 16, 2022

Jeffrey W. Fisher is the recipient of the Arnold J Lehman SOT award

Career achievement for contributions in Physiologically based pharmacokinetic (PBPK) and biologically based does response (BBDR) modelling tools


UFDA approves first generic of Symbicort to treat asthma and COPD
Drug Approval | March 16, 2022

UFDA approves first generic of Symbicort to treat asthma and COPD

This drug-device combination product is a metered-dose inhaler (MDI), which contains both budesonide (a corticosteroid that reduces inflammation) and formoterol (a long-acting bronchodilator that relaxes muscles in the airways to improve breathing)


Sanofi and Seagen to jointly develop multiple novel antibody-drug conjugates
Biotech | March 16, 2022

Sanofi and Seagen to jointly develop multiple novel antibody-drug conjugates

Jointly fund and develop up to three antibody-drug conjugate programs for the treatment of cancer